EIF4EBP3 and cancer: To study the function of 4E-BP3 downstream of mTORC1, we examined the effect of mTOR inhibitors (rapamycin, or asTORi, INK1341 and PP242) on the expression of 4E-BP3 in a panel of human cancer cell lines.